Back to Search
Start Over
Adalimumab Biosimilars Insight, 2020 | DelveInsight Report Analysis
- Source :
- M2 Presswire. March 5, 2021
- Publication Year :
- 2021
-
Abstract
- M2 PRESSWIRE-March 5, 2021-: Adalimumab Biosimilars Insight, 2020 | DelveInsight Report Analysis (C)1994-2021 M2 COMMUNICATIONS RDATE:04032021 DelveInsight's, 'Adalimumab Biosimilar Insight, 2020,' report provides comprehensive insights about 35+ companies and 45+ [...]
- Subjects :
- Pfizer Inc. -- Forecasts and trends
Psoriasis -- Forecasts and trends -- Reports
Rheumatoid factor -- Reports -- Forecasts and trends
Homeopathy -- Materia medica and therapeutics
Therapeutics -- Prices and rates
Arthritis -- Reports -- Forecasts and trends
Adalimumab -- Prices and rates
Pharmaceutical industry -- Forecasts and trends
Market trend/market analysis
Company pricing policy
Business
Business, international
Humira (Medication) -- Prices and rates
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Presswire
- Publication Type :
- News
- Accession number :
- edsgcl.653886586